Former Texas Governor and Trump Cabinet Member Helped Position Texas as Psychedelics Research Leader

Texas is making a massive $50 million bet on ibogaine, a psychedelic plant extract, to combat addiction and brain trauma. Governor Greg Abbott recently signed a law establishing a research consortium to push for FDA approval, positioning the Lone Star State as a global leader in psychedelic investment. Interestingly, this push is spearheaded by former Governor Rick Perry, a staunch conservative who changed his tune after seeing how these treatments helped veterans struggling with PTSD and opioid dependency.

While Texas continues to play hardball with recreational cannabis, this shift toward medical psychedelics is a fascinating development for our community. It shows that even the most traditional leaders can’t ignore the scientific data when it comes to plant-based healing. For regular users, this move is a win because it further destigmatizes "alternative" medicines and proves that the tide is turning on drug policy, even in unexpected places. If Texas can successfully mainstream a powerful psychedelic for veterans, it paves a much smoother road for broader cannabis and plant-medicine accessibility everywhere.